Annual Total Liabilities
$34.02 M
-$9.22 M-21.33%
December 31, 2023
Summary
- As of February 8, 2025, VXRT annual total liabilities is $34.02 million, with the most recent change of -$9.22 million (-21.33%) on December 31, 2023.
- During the last 3 years, VXRT annual total liabilities has risen by +$4.85 million (+16.61%).
- VXRT annual total liabilities is now -79.69% below its all-time high of $167.51 million, reached on December 31, 2005.
Performance
VXRT Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$98.23 M
+$64.50 M+191.19%
September 30, 2024
Summary
- As of February 8, 2025, VXRT quarterly total liabilities is $98.23 million, with the most recent change of +$64.50 million (+191.19%) on September 30, 2024.
- Over the past year, VXRT quarterly total liabilities has increased by +$64.11 million (+187.89%).
- VXRT quarterly total liabilities is now -45.88% below its all-time high of $181.50 million, reached on June 25, 2005.
Performance
VXRT Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
VXRT Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.3% | +187.9% |
| 3 y3 years | +16.6% | +145.0% |
| 5 y5 years | +41.8% | +145.0% |
VXRT Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -21.3% | +1.1% | at high | +197.8% |
| 5 y | 5-year | -21.3% | +41.3% | at high | +361.8% |
| alltime | all time | -79.7% | +507.6% | -45.9% | +1654.1% |
Vaxart Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $98.23 M(+191.2%) |
| Jun 2024 | - | $33.73 M(+2.3%) |
| Mar 2024 | - | $32.98 M(-3.1%) |
| Dec 2023 | $34.02 M(-21.3%) | $34.02 M(-0.3%) |
| Sep 2023 | - | $34.12 M(-9.2%) |
| Jun 2023 | - | $37.58 M(-6.3%) |
| Mar 2023 | - | $40.10 M(-7.3%) |
| Dec 2022 | $43.25 M(+28.6%) | $43.25 M(-18.4%) |
| Sep 2022 | - | $53.00 M(+38.2%) |
| Jun 2022 | - | $38.36 M(+12.8%) |
| Mar 2022 | - | $34.01 M(+1.1%) |
| Dec 2021 | $33.64 M(+15.3%) | $33.64 M(-7.0%) |
| Sep 2021 | - | $36.19 M(+24.5%) |
| Jun 2021 | - | $29.06 M(-1.9%) |
| Mar 2021 | - | $29.63 M(+1.6%) |
| Dec 2020 | $29.18 M(+21.2%) | $29.18 M(+26.7%) |
| Sep 2020 | - | $23.03 M(-3.9%) |
| Jun 2020 | - | $23.95 M(+12.6%) |
| Mar 2020 | - | $21.27 M(-11.7%) |
| Dec 2019 | $24.08 M(+0.4%) | $24.08 M(+1.2%) |
| Sep 2019 | - | $23.79 M(+11.2%) |
| Jun 2019 | - | $21.41 M(-9.8%) |
| Mar 2019 | - | $23.73 M(-1.1%) |
| Dec 2018 | $23.99 M(+12.1%) | $23.99 M(-2.7%) |
| Sep 2018 | - | $24.65 M(-3.0%) |
| Jun 2018 | - | $25.41 M(-0.1%) |
| Mar 2018 | - | $25.43 M(+16.7%) |
| Dec 2017 | - | $21.80 M(+4.8%) |
| Sep 2017 | - | $20.80 M(-2.8%) |
| Jun 2017 | $21.40 M(-19.2%) | $21.40 M(-4.9%) |
| Mar 2017 | - | $22.50 M(-21.1%) |
| Dec 2016 | - | $28.50 M(+7.5%) |
| Sep 2016 | - | $26.50 M(0.0%) |
| Jun 2016 | $26.50 M(+167.7%) | $26.50 M(+188.0%) |
| Mar 2016 | - | $9.20 M(+37.3%) |
| Dec 2015 | - | $6.70 M(-10.7%) |
| Sep 2015 | - | $7.50 M(-24.2%) |
| Jun 2015 | $9.90 M(-63.5%) | $9.90 M(+35.6%) |
| Mar 2015 | - | $7.30 M(-33.6%) |
| Dec 2014 | - | $11.00 M(-43.3%) |
| Sep 2014 | - | $19.40 M(-28.4%) |
| Jun 2014 | $27.10 M(+52.2%) | $27.10 M(+10.6%) |
| Mar 2014 | - | $24.50 M(+32.4%) |
| Dec 2013 | - | $18.50 M(+31.2%) |
| Sep 2013 | - | $14.10 M(-20.8%) |
| Jun 2013 | $17.80 M(-54.5%) | $17.80 M(+20.8%) |
| Mar 2013 | - | $14.73 M(-14.4%) |
| Dec 2012 | - | $17.22 M(-52.9%) |
| Sep 2012 | - | $36.54 M(+2.6%) |
| Jun 2012 | - | $35.62 M(-0.6%) |
| Mar 2012 | - | $35.83 M(-8.4%) |
| Dec 2011 | $39.09 M(-26.7%) | $39.09 M(-9.8%) |
| Sep 2011 | - | $43.36 M(-5.0%) |
| Jun 2011 | - | $45.64 M(-4.0%) |
| Mar 2011 | - | $47.53 M(-10.8%) |
| Dec 2010 | $53.30 M(+57.2%) | $53.30 M(-4.5%) |
| Sep 2010 | - | $55.81 M(-8.0%) |
| Jun 2010 | - | $60.66 M(-11.8%) |
| Mar 2010 | - | $68.75 M(+102.7%) |
| Dec 2009 | $33.91 M(+48.5%) | $33.91 M(+170.3%) |
| Sep 2009 | - | $12.55 M(+4.4%) |
| Jun 2009 | - | $12.01 M(-46.6%) |
| Mar 2009 | - | $22.49 M(-1.5%) |
| Dec 2008 | $22.84 M(-75.2%) | $22.84 M(-47.3%) |
| Sep 2008 | - | $43.35 M(-14.0%) |
| Jun 2008 | - | $50.40 M(-43.9%) |
| Mar 2008 | - | $89.82 M(-2.4%) |
| Dec 2007 | $92.04 M(-40.4%) | $92.04 M(-34.6%) |
| Sep 2007 | - | $140.70 M(+4.4%) |
| Jun 2007 | - | $134.80 M(-2.4%) |
| Mar 2007 | - | $138.18 M(-10.6%) |
| Dec 2006 | $154.49 M | $154.49 M(-6.1%) |
| Sep 2006 | - | $164.58 M(+4.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2006 | - | $157.51 M(-0.7%) |
| Mar 2006 | - | $158.55 M(-5.3%) |
| Dec 2005 | $167.51 M(+99.8%) | $167.51 M(-6.3%) |
| Sep 2005 | - | $178.73 M(-1.5%) |
| Jun 2005 | - | $181.50 M(+199.3%) |
| Mar 2005 | - | $60.63 M(-27.7%) |
| Dec 2004 | $83.85 M(+23.3%) | $83.85 M(+7.2%) |
| Sep 2004 | - | $78.24 M(-2.9%) |
| Jun 2004 | - | $80.57 M(+23.5%) |
| Mar 2004 | - | $65.24 M(-4.0%) |
| Dec 2003 | $67.98 M(+55.3%) | $67.98 M(-10.5%) |
| Sep 2003 | - | $75.96 M(+76.2%) |
| Jun 2003 | - | $43.10 M(+19.2%) |
| Mar 2003 | - | $36.14 M(-17.5%) |
| Dec 2002 | $43.79 M(-64.4%) | $43.79 M(+29.2%) |
| Sep 2002 | - | $33.90 M(-0.2%) |
| Jun 2002 | - | $33.96 M(-68.8%) |
| Mar 2002 | - | $108.98 M(-11.5%) |
| Dec 2001 | $123.10 M(-16.3%) | $123.10 M(+6.0%) |
| Sep 2001 | - | $116.18 M(-16.7%) |
| Jun 2001 | - | $139.44 M(+1.2%) |
| Mar 2001 | - | $137.73 M(-6.4%) |
| Dec 2000 | $147.09 M(-6.0%) | $147.09 M(+5.3%) |
| Sep 2000 | - | $139.65 M(-6.6%) |
| Jun 2000 | - | $149.45 M(+5.1%) |
| Mar 2000 | - | $142.16 M(-9.1%) |
| Dec 1999 | $156.40 M(-4.7%) | $156.40 M(+6.4%) |
| Sep 1999 | - | $147.00 M(-0.5%) |
| Jun 1999 | - | $147.70 M(-5.4%) |
| Mar 1999 | - | $156.10 M(-4.9%) |
| Dec 1998 | $164.10 M(+9.3%) | $164.10 M(+15.1%) |
| Sep 1998 | - | $142.60 M(+0.1%) |
| Jun 1998 | - | $142.50 M(-5.4%) |
| Mar 1998 | - | $150.60 M(+0.3%) |
| Dec 1997 | $150.20 M(+29.5%) | $150.20 M(+5.7%) |
| Sep 1997 | - | $142.10 M(+15.5%) |
| Jun 1997 | - | $123.00 M(+2.7%) |
| Mar 1997 | - | $119.80 M(+3.3%) |
| Dec 1996 | $116.00 M(+69.1%) | $116.00 M(-0.3%) |
| Sep 1996 | - | $116.30 M(+2.7%) |
| Jun 1996 | - | $113.20 M(-0.3%) |
| Mar 1996 | - | $113.50 M(+65.5%) |
| Dec 1995 | $68.60 M(+63.3%) | $68.60 M(+19.5%) |
| Sep 1995 | - | $57.40 M(+19.3%) |
| Jun 1995 | - | $48.10 M(+14.8%) |
| Mar 1995 | - | $41.90 M(-0.2%) |
| Dec 1994 | $42.00 M(+20.3%) | $42.00 M(-16.0%) |
| Sep 1994 | - | $50.00 M(+4.6%) |
| Jun 1994 | - | $47.80 M(+4.1%) |
| Mar 1994 | - | $45.90 M(+31.5%) |
| Dec 1993 | $34.90 M(+3.9%) | $34.90 M(-4.1%) |
| Sep 1993 | - | $36.40 M(+6.4%) |
| Jun 1993 | - | $34.20 M(+5.6%) |
| Mar 1993 | - | $32.40 M(-3.6%) |
| Dec 1992 | $33.60 M(+192.2%) | $33.60 M(+1.2%) |
| Sep 1992 | - | $33.20 M(+7.8%) |
| Jun 1992 | - | $30.80 M(+2.3%) |
| Mar 1992 | - | $30.10 M(+161.7%) |
| Dec 1991 | $11.50 M(-0.9%) | $11.50 M(-10.9%) |
| Sep 1991 | - | $12.90 M(+55.4%) |
| Jun 1991 | - | $8.30 M(-9.8%) |
| Mar 1991 | - | $9.20 M(-20.7%) |
| Dec 1990 | $11.60 M(-21.1%) | $11.60 M(-20.0%) |
| Sep 1990 | - | $14.50 M(+9.0%) |
| Jun 1990 | - | $13.30 M(-2.2%) |
| Mar 1990 | - | $13.60 M(-7.5%) |
| Dec 1989 | $14.70 M(+16.7%) | $14.70 M(+7.3%) |
| Sep 1989 | - | $13.70 M(+10.5%) |
| Jun 1989 | - | $12.40 M(-1.6%) |
| Dec 1988 | $12.60 M(+125.0%) | $12.60 M(+125.0%) |
| Dec 1987 | $5.60 M(-23.3%) | $5.60 M(-23.3%) |
| Dec 1986 | $7.30 M(0.0%) | $7.30 M(0.0%) |
| Dec 1985 | $7.30 M | $7.30 M |
FAQ
- What is Vaxart annual total liabilities?
- What is the all time high annual total liabilities for Vaxart?
- What is Vaxart annual total liabilities year-on-year change?
- What is Vaxart quarterly total liabilities?
- What is the all time high quarterly total liabilities for Vaxart?
- What is Vaxart quarterly total liabilities year-on-year change?
What is Vaxart annual total liabilities?
The current annual total liabilities of VXRT is $34.02 M
What is the all time high annual total liabilities for Vaxart?
Vaxart all-time high annual total liabilities is $167.51 M
What is Vaxart annual total liabilities year-on-year change?
Over the past year, VXRT annual total liabilities has changed by -$9.22 M (-21.33%)
What is Vaxart quarterly total liabilities?
The current quarterly total liabilities of VXRT is $98.23 M
What is the all time high quarterly total liabilities for Vaxart?
Vaxart all-time high quarterly total liabilities is $181.50 M
What is Vaxart quarterly total liabilities year-on-year change?
Over the past year, VXRT quarterly total liabilities has changed by +$64.11 M (+187.89%)